Motility News

Though I see some interesting mirrors between pediatric and adult gastroenterology in the management of constipation, this month’s cover story brings to light the added hurdles our pediatric gastroenterologists must conquer when treating their patients.

FDA has granted Cosmo Pharmaceuticals fast track and qualified infectious disease product designations for Aemcolo, an investigational treatment for patients with travelers’ diarrhea, according to a recent press release.

ORLANDO — An intraluminal vibrating capsule called Vibrant safely relieved moderate-to-severe chronic idiopathic constipation in a dose-dependent manner, according to trial results presented at the World Congress of Gastroenterology at ACG 2017.

A new American Gastroenterological Association Clinical Practice Update provides guidance on managing the gastrointestinal symptoms and side effects of opioids.

CHICAGO — The increasing news coverage of gastrointestinal conditions and their treatments have spurred the spread of misinformation, especially concerning the use of MiraLAX for treating constipation, according to a recent presentation at the AAP 2017 National Conference & Exhibition.

Modern medicine has increasingly recognized the biochemical interaction of the central nervous system and the gastrointestinal tract, known as the “gut-brain axis.” Until recently, though, many practitioners considered functional gastrointestinal conditions such as irritable bowel syndrome to be psychosomatic.

Nearly 18% of patients who underwent primary laparoscopic antireflux surgery experienced recurrent gastroesophageal reflux necessitating secondary antireflux surgery or long-term medication use, according to findings recently published in JAMA.

Transoral incisionless fundoplication with the EsophyX device provided long-term control of GERD symptoms through 4 years of follow-up, according to new data from the TEMPO trial presented at Minimally Invasive Surgery Week, the Society of Laparoendoscopic Surgeons 2017 annual meeting.

Patients with laryngopharyngeal reflux who adhered to a plant-based Mediterranean-style diet paired with alkaline water achieved similar or better symptom improvement as those treated with PPIs, according to new research.

Half of patients surveyed reported their physician did not discuss constipation as a side effect of opioid medication while one-third report never discussing drug-drug interactions despite 80% taking more than five medications, according to a survey conducted by Salix Pharmaceuticals in partnership with U.S. Pain Foundation.